U.S. Tech Hardware Stock News

If you are wondering whether Monster Beverage's share price still offers value after a strong run, this article walks through what the current valuation might be telling you. The stock last closed at US$86.66, with returns of 5.7% over 7 days, 6.4% over 30 days, 13.8% year to date, 66.9% over 1 year, 69.7% over 3 years and 104.7% over 5 years. These figures raise fair questions about whether the current price fully reflects the company's prospects or risk profile. Recent coverage has focused...

If you are wondering whether Centrus Energy shares still offer value after a strong run, the starting point is to understand what the current price is really giving you. The stock last closed at US$210.96, with returns of 1.0% over 7 days, a 31.8% decline over 30 days, a 22.6% decline year to date, and a 135.7% gain over the past year. This can signal shifting expectations around both opportunity and risk. Recent news coverage has focused on Centrus Energy's role in the nuclear fuel supply...

VSE Corporation recently reported Q4 2025 results that exceeded analyst expectations on both revenue and earnings, with operating margin improving to 10.8%, and issued full‑year 2026 guidance calling for approximately 19% to 23% revenue growth supported by the Aero 3 and Turbine Weld acquisitions. Alongside affirming a regular US$0.10 per‑share quarterly dividend, VSE marked its first year above US$1.00 billion in aviation revenue after completing its shift to a pure aviation aftermarket...

If you are wondering whether Cohen & Steers is attractively priced right now, this article walks through what the current share price may or may not be reflecting about its underlying value. The stock last closed at US$67.14, with returns of 0.4% over 7 days, 3.1% over 30 days, 5.6% year to date, 4.1% over 3 years and 22.0% over 5 years, alongside a 19.7% decline over the past year that some investors may see as a reset in expectations. Recent news coverage has focused on Cohen & Steers as a...

In late February 2026, AdaptHealth Corp. reported full-year 2025 results showing net revenue of US$3,244.86 million and a net loss of US$70.79 million, driven in part by a US$127.99 million goodwill impairment, while also outlining 2026 revenue guidance of US$3.44 billion to US$3.51 billion. Alongside these results, management highlighted record patient volumes, the launch of a large capitated contract, and fresh home medical equipment acquisitions funded partly by a US$100 million revolver...

Safety Insurance Group (SAFT) has wrapped up FY 2025 with Q4 revenue of US$319.3 million and basic EPS of US$1.37, rounding out a year in which trailing twelve month revenue reached about US$1.26 billion and EPS came in at US$6.75. Over recent quarters, the company has seen revenue move from US$286.7 million and EPS of US$0.55 in Q4 2024 to the latest Q4 2025 levels. The trailing net profit margin of 7.9% sits above the 6.3% recorded a year earlier, setting up a results season where higher...

Event context and recent share performance Ligand Pharmaceuticals (LGND) has been drawing attention after a period of mixed share performance, with a roughly 0.3% gain over the past month and a 3.5% decline over the past 3 months. For investors tracking the name, the recent 1 day move of about 2.5% and 1 week return of roughly 5.3% sit alongside a 1 year total return near 70%, all against a last close of US$196.17. See our latest analysis for Ligand Pharmaceuticals. The recent 2.5% 1 day...

Globe Life (GL) has raised its quarterly dividend to US$0.33 per share and set payment for May 1, 2026. The company has also added Derek T. Kan and Sandra L. Phillips to its board. See our latest analysis for Globe Life. At a share price of US$146.08, Globe Life has seen a 6.33% 30 day share price return and an 8.42% 90 day share price return. Its 1 year total shareholder return of 18.60% suggests recent momentum has added to longer term gains, with the dividend increase and board refresh...

If you are wondering whether Advanced Micro Devices (AMD) still offers value at current levels, this article will walk through what the market price might be implying about the stock. AMD last closed at US$203.68, with returns of 0.2% over the past 7 days, a 19.2% decline over the past 30 days, a 8.9% decline year to date, a 104.7% return over 1 year and 153.2% over 3 years. These moves have come alongside continued attention on AMD as a major player in high performance computing and...

In recent months, MSCI has reported solid Q4 2025 results while rolling out AI-powered data tools, renewing its long-term ETF agreement with BlackRock, collaborating with Allfunds, and entering a new agreement with the NYSE to deepen its role in investment data and index infrastructure. Taken together, these moves suggest MSCI is working to embed its data and analytics more deeply across client workflows, potentially reinforcing the recurring nature and breadth of its revenue streams. Now...

Krystal Biotech reported fourth-quarter 2025 net income of US$51.4 million and full-year net income of US$204.83 million, with both basic and diluted earnings per share increasing compared with the prior year. Alongside these stronger earnings, the company is drawing heightened attention from Wall Street and industry events, as analysts reiterate positive views on its genetic medicines platform and leadership participates in high-profile healthcare conferences. With this earnings momentum as...

In late February 2026, Keysight Technologies reported first-quarter revenue of US$1.60 billion and net income of US$281 million, issued second-quarter guidance implying very strong year-on-year growth, and highlighted demand from AI data centers, next-generation connectivity, and defense as key drivers. Beyond the headline beat, Keysight’s flurry of new test solutions for AI data centers, 6G, satellite connectivity, and intelligent AI-RAN at Mobile World Congress 2026 underscored how deeply...

Philip Morris International (NYSE:PM) is accelerating its shift away from combustible cigarettes toward smoke free products. The company is highlighting rapid growth for its oral nicotine brand Zyn as a key part of this transition. PMI has expanded smoke free offerings into more than 100 markets as part of this push. The company has set an internal target for around two thirds of its revenue to come from smoke free products by 2030. For you as an investor, this marks a meaningful phase for...

Frontdoor FY 2025 earnings set the stage for the next chapter Frontdoor (FTDR) has reported its FY 2025 figures, with fourth quarter revenue at US$433 million and basic EPS of US$0.03, alongside trailing twelve month revenue of about US$2.1 billion and EPS of US$3.49 providing the broader context. The company’s quarterly revenue has moved from US$382 million and EPS of US$0.12 in Q4 2024 to US$433 million and EPS of US$0.03 in Q4 2025. Trailing twelve month net income has ranged between...

If you are wondering whether Five Below’s current share price still offers value after a strong run, you are not alone. The stock recently closed at US$225.12, with returns of 4.2% over 7 days, 20.2% over 30 days, 16.4% year to date and 157.5% over 1 year. This naturally raises questions about the balance between return potential and risk. Recent coverage around Five Below has focused on its position as a discount retailer and how investors are thinking about consumer spending and store...

Elevance Health recently announced that Peter D. Haytaian will transition from his role as Executive Vice President and President of Carelon, shifting to a Special Advisor position through the end of 2026 to support leadership transition and operational continuity in its health services division. Haytaian’s planned departure, combined with expanded responsibilities for other senior leaders, comes as Elevance reaffirms its 2026 earnings guidance and continues to position Carelon at the center...

OUTFRONT Media (OUT) closed out FY 2025 with Q4 revenue of US$513.3 million and basic EPS of US$0.57, alongside funds from operations of US$136.9 million, putting the focus squarely on how its core out of home platform is translating into cash generation. Over recent quarters the company has seen revenue move from US$390.7 million in Q1 2025 to US$467.5 million in Q3 and US$513.3 million in Q4, while basic EPS shifted from a loss of US$0.14 in Q1 to US$0.29 in Q3 and US$0.57 in Q4. This gives...

LeMaitre Vascular (LMAT) closed out FY 2025 with Q4 revenue of US$64.5 million and EPS of US$0.69, while trailing 12 month revenue reached US$249.6 million and EPS came in at US$2.55 on net income of US$57.7 million. Over the past six reported quarters, the company has seen quarterly revenue move from US$54.8 million in Q3 2024 to between roughly US$59.9 million and US$64.5 million in FY 2025, with quarterly EPS ranging from US$0.49 to US$0.77. This points to a story where higher earnings are...

Analog Devices (NasdaqGS:ADI) reported very strong quarterly revenue and earnings, with growth outpacing peers. The company announced an 11% dividend increase, reinforcing its focus on shareholder returns. These results highlight solid momentum across core business segments and confidence in future performance. For investors watching NasdaqGS:ADI, the latest update comes alongside a share price of $354.35 and robust recent gains, including 16.6% over the past month and 60.9% over the past...

Earlier this week, Li Auto joined the Brussels-based China Chamber of Commerce to the EU as a full member, deepening its European expansion through an R&D center in Munich, new overseas retail locations, and hiring local sales leaders to build a compliant, localized operation. This move signals Li Auto’s push to shift from reliance on parallel exports toward direct engagement with EU regulators and premium competitors, potentially reshaping its role in the global EV landscape. We’ll now...

Salesforce FY 2026 earnings snapshot Salesforce (CRM) has just wrapped up FY 2026 with Q4 revenue of US$11.2b and basic EPS of US$2.08, setting the tone for a year where investors are watching how top line scale and per share profitability move together. The company has seen quarterly revenue move from US$9.8b in Q1 FY 2026 to US$11.2b in Q4, with basic EPS ranging from US$1.61 to US$2.20 over the same stretch. Trailing 12 month revenue reached US$41.5b and EPS came in at US$7.85. Taken...

If you are wondering whether Huron Consulting Group shares are attractively priced or asking too much, you are in the right place for a clear look at value. The stock most recently closed at US$143.29, with returns of 9.4% over 7 days, a 15.7% decline over 30 days, a 16.2% decline year to date, and a 4.2% decline over 1 year, set against a 73.0% return over 3 years and 174.7% over 5 years. Recent news around Huron has focused on its role as a consulting partner helping organizations handle...

In February 2026, Larimar Therapeutics announced that the FDA granted Breakthrough Therapy Designation to nomlabofusp for treating adults and children with Friedreich’s ataxia, while the company advanced plans for an accelerated Biologics License Application supported by skin frataxin as a novel surrogate endpoint. This combination of expedited regulatory status and FDA alignment on using a new biomarker underscores how central nomlabofusp has become to Larimar’s clinical and regulatory...

If you are wondering whether Las Vegas Sands is offering fair value at its current share price, you are not alone. This article walks through how that price stacks up against several valuation checks. The stock last closed at US$55.95, with returns of a 3.7% decline over 7 days, a 7.3% decline over 30 days, a 14.2% decline year to date, and a 30.6% gain over the past year. This can signal that market sentiment has shifted over different time frames. Recent moves in Las Vegas Sands shares...